← Open Payments lookup

NATHALIE ORR: Open Payments

NPI 1417316357 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$975 in 45 payments from 15 companies in 2025. Trend: 2023 $842 · 2024 $1,041 · 2025 $975

Food & beverage: $975
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.8$171
Janssen Biotech, Inc.7$151
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$133
Madrigal Pharmaceuticals4$116
ABBVIE INC.5$87
Regeneron Healthcare Solutions, Inc.4$76
Lilly USA, LLC2$44
Ipsen Biopharmaceuticals, Inc1$34
Celltrion USA Inc.2$34
GENZYME CORPORATION1$26

Products named: TREMFYA, XIFAXAN, REZDIFFRA, DUPIXENT, ENTYVIO, RINVOQ, GATTEX, OMVOH.

Industry payments across MD — which companies pay providers there.